{"id":"https://openalex.org/W4361819224","doi":"https://doi.org/10.1158/0008-5472.22429711","title":"Supplementary File 3 from BRAF Inhibitors Reprogram Cancer-Associated Fibroblasts to Drive Matrix Remodeling and Therapeutic Escape in Melanoma","display_name":"Supplementary File 3 from BRAF Inhibitors Reprogram Cancer-Associated Fibroblasts to Drive Matrix Remodeling and Therapeutic Escape in Melanoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361819224","doi":"https://doi.org/10.1158/0008-5472.22429711"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22429711","doi":"https://doi.org/10.1158/0008-5472.22429711","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22429711","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_File_3_from_BRAF_Inhibitors_Reprogram_Cancer-Associated_Fibroblasts_to_Drive_Matrix_Remodeling_and_Therapeutic_Escape_in_Melanoma/22429711/1/files/39876043.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_File_3_from_BRAF_Inhibitors_Reprogram_Cancer-Associated_Fibroblasts_to_Drive_Matrix_Remodeling_and_Therapeutic_Escape_in_Melanoma/22429711/1/files/39876043.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100430602","display_name":"Tianyi Liu","orcid":"https://orcid.org/0000-0002-2624-7146","observed_orcids":["https://orcid.org/0000-0002-2624-7146"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tianyi Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2624-7146","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084148508","display_name":"Linli Zhou","orcid":"https://orcid.org/0000-0003-1713-354X","observed_orcids":["https://orcid.org/0000-0003-1713-354X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linli Zhou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1713-354X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100701346","display_name":"Yao Xiao","orcid":"https://orcid.org/0000-0003-0224-8424","observed_orcids":["https://orcid.org/0000-0003-0224-8424"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yao Xiao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013343878","display_name":"Thomas Andl","orcid":"https://orcid.org/0009-0006-7163-3624","observed_orcids":["https://orcid.org/0009-0006-7163-3624","https://orcid.org/0000-0002-5555-468X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Andl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100321510","display_name":"Yuhang Zhang","orcid":"https://orcid.org/0000-0003-3825-0796","observed_orcids":["https://orcid.org/0000-0003-3825-0796"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuhang Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.9399999976158142},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.9950000047683716},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/matrix-remodeling","display_name":"matrix remodeling","score":0.7879999876022339},{"id":"https://openalex.org/keywords/therapeutic-escape","display_name":"therapeutic escape","score":0.9589999914169312},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.7200000286102295},{"id":"https://openalex.org/keywords/nras-mutation","display_name":"NRAS mutation","score":0.9559999704360962},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6157897710800171},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5991196036338806},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43257948756217957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36888182163238525},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32186204195022583},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1668582558631897}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.22429711","doi":"https://doi.org/10.1158/0008-5472.22429711","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22429711","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_File_3_from_BRAF_Inhibitors_Reprogram_Cancer-Associated_Fibroblasts_to_Drive_Matrix_Remodeling_and_Therapeutic_Escape_in_Melanoma/22429711/1/files/39876043.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22429711","doi":"https://doi.org/10.1158/0008-5472.22429711","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22429711","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_File_3_from_BRAF_Inhibitors_Reprogram_Cancer-Associated_Fibroblasts_to_Drive_Matrix_Remodeling_and_Therapeutic_Escape_in_Melanoma/22429711/1/files/39876043.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361819224.pdf","grobid_xml":"https://content.openalex.org/works/W4361819224.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4226072808","https://openalex.org/W4392723388","https://openalex.org/W3180260704","https://openalex.org/W4393095802","https://openalex.org/W4361937885","https://openalex.org/W4393093759","https://openalex.org/W4362411434","https://openalex.org/W4362432593","https://openalex.org/W4361937495","https://openalex.org/W4361937791"],"abstract_inverted_index":{"Supplementary":[0],"File":[1],"3":[2],"CAF":[3],"sequencing":[4],"BRAF":[5],"and":[6],"NRAS":[7],"results":[8]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2023-04-05T00:00:00"}